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Brucellosis is an important zoonotic animal disease, 
transmissible to man. Brucella research recently has 
been marked with the discovery of a number of novel 
species and hosts therein. Isolation of newer Brucella-
like bacteria in recent years from marine mammals 
became a significant new development. These bacteria 
were shown to cause a wide variety of reproductive 
disorders, including abortion and meningoencephalitis 
among marine mammals. Three human cases with 
naturally acquired infection and one case of labora-
tory-acquired infection by Brucella strains of marine 
origin have put these novel marine brucellae in the 
same category of zoonoses of concern. 
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Background 
BRUCELLOSIS is an economically important disease  
affecting animals and man. It ranks among the major 
zoonotic diseases. Brucellosis, which remains an under-
reported and neglected disease, causes significant medical, 
veterinary and socio-economic problems. The economic 
impact of the disease on the animal industry is reflected 
by reduced production and high costs towards its man-
agement due to reproductive disorders (abortion, stillbirth 
and sterility), reduced milk, meat and wool yield, poor 
health of animals, loss of progenies, vaccination, testing, 
segregation and slaughter of infected animals. Dairy cat-
tle, goat, sheep and swine are the main species involved 
among the domestic animals. The disease has also been 
reported in recent years from wild terrestrial and marine 
mammals. Cross-infections between different species add 
to the complexity of the disease1. 
 Around the globe, more than 500,000 human infections 
are reported annually2. Human brucellosis, with its his-
torical background in the Mediterranean countries, is 
known by various names – Malta fever, Mediterranean 
fever, Gibraltar fever and rock fever. The disease in hu-
mans in modern times is more popularly known as undu-
lant fever on account of the undulating nature of febrile 
reaction in clinical cases3. The understanding of patho-
genic mechanisms, severity and progression of the infec-
tion, treatment responses, vaccine and rapid diagnostic 
tests and development of improved treatment regimens 
against brucellosis in man and animals is still posing 
challenges3. 
 Due to their high infectivity and fastidious nature, 
Brucella spp. are a major potential bioterrorism threat 
and the Centers for Disease Control and Prevention, USA 
has classified them as category-B agents4. Lack of suffi-
cient knowledge about the disease among physicians,  
under diagnosis or misdiagnosis and absence of effective 
disease management strategies are attributed to the spread 
of this disease among human populations3. Cases of  
human brucellosis are often misdiagnosed as typhoid and 
tuberculosis3. Long duration of expensive treatment  
decreases its efficacy in controlling the disease in humans. 
Therefore, the World Health Organization (WHO) has  
delineated the development of effective human vaccine-
mediated control and eradication programme as a major 
cornerstone for the management of human brucellosis5. 
Introduction 
Brucellosis was first reported in Malta by Marston in 
1859. In 1887, David Bruce isolated the causative organ-
ism from the spleens of the fatally infected soldiers in 
Malta and the bacterium was named as Micrococcous  
melitensis. Wright and Smith (1897) were the first to  
describe a serological diagnostic test for M. melitensis in 
man and animals, which indicated the zoonotic potential 
of the disease. Zammit (1905) isolated the bacterium 
from goats. He further concluded that goats are the natu-
ral reservoirs for M. melitensis and consumption of raw 
milk and cheese infects man. In 1920, Meyer and Shaw 
proposed a new generic name, Brucella, for the organ-
ism1,2. 
 The eco-epidemiological significance of Brucella spe-
cies lies in its host propensity and hosts for all these spe-
cies of Brucella are different terrestrial mammals. The 
classical strains of Brucella, namely B. melitensis, B. 
abortus, B. suis, B. ovis, B. neotomae and B. canis are  
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associated with specific animal species. Among the 
smooth strains, B. melitensis chiefly infects goats and 
sheep, with some reports in cattle and buffaloes; B. abor-
tus infects mainly cattle and buffalo. Primary host of B. 
suis is swine and that of B. neotomae is desert wood-rat. 
B. canis and B. ovis are the two rough strains causing  
infection, particularly in dogs and rams respectively. 
Among brucellae, B. melitensis is the most zoonotic fol-
lowed by B. suis, B. abortus and B. canis. These strains 
can also infect animals other than their preferred hosts3. 
 Brucellosis is a re-emerging zoonosis with continu-
ously evolving epidemiology because of the emergence 
of novel Brucella strains. It has established itself in new 
hosts and ecological niches. During 1990s, new Brucella 
species were reported from the marine mammals and 
were initially named as B. maris6,7. Later, B. microti was 
isolated from common voles and red foxes and also iden-
tified as soil contaminant in Central Europe8. Two novel 
strains, B. inopinata and another similar to B. inopinata, 
have been isolated from a human breast implant and from 
a patient with chronic lung disease9. The natural reser-
voirs and ecology of these two strains remain unknown. 
A bacterial strain with Brucella-like characteristics but 
distinct from the currently described species has been  
reported from two baboons with stillbirth10. Recently, two 
atypical Brucella strains were isolated from wild red 
foxes (Vulpes vulpes) in eastern Austria11. These isolates 
had negative nitrate reductase and negative oxidase reac-
tions which are atypical to genus Brucella. However, on 
the basis of serology and molecular analysis, it has been 
suggested that both strains possibly represent a novel 
Brucella species. 
 The present review article focuses on the etiology, epi-
demiology and diagnosis of brucellosis in marine mam-
mals and its zoonotic implications. The marine Brucella 
isolates may act as etiological agents for various repro-
ductive disorders in sea mammals (cetaceans and pin-
nipeds) leading to abortion and stillbirth, and can be of 
concern for the existence of threatened marine mammal 
species. Marine Brucella strains represent a zoonotic 
threat; however, the pathogenicity of these microorgan-
isms to humans is yet to be clearly established. Sea 
mammals can also introduce brucellosis to new hosts and 
new areas, as their movement is independent of political 
and geographical boundaries. 
Etiology and epidemiology of marine  
brucellosis 
Isolation of Brucella spp. from marine mammals was  
reported for the first time in 1994 from stranded common 
seals (Phoca vitulina), harbour porpoises (Phocoena pho-
coena) and dolphins (Delphinus delphis) around the coast 
of Scotland6. In the same year the organism was also  
recovered from the aborted foetus of a bottlenose dolphin 
(Tursiops truncates) in California7. This new strain,  
initially designated as Brucella maris, was further  
divided into biovar 1 (isolated from seals and otters), bio-
var 2 (from cetaceans) and biovar 3 (from Californian 
bottlenose dolphin)12. Marine mammalian Brucella iso-
lates have a host preference for either the order Cetacea 
(whales, dolphins and porpoises) or Pinnipedia (seals, sea 
lions and walruses), with the exception of one isolate 
which was recovered from sea otter (family Mustilidae 
and order Carnivora). The strains isolated from seals are 
different compared to those isolated from cetaceans13. 
Later on, two new species names were proposed, i.e.  
B. cetaceae for cetacean isolates and B. pinnipediae for 
pinniped isolates instead of B. maris14. Bergey’s Manual 
of Systematic Bacteriology had described three novel 
Brucella species from marine mammals as B. phocae 
(seals), B. phoecoenae (porpoises) and B. delphini (dol-
phins)15. In addition, other nomenclatures based on vari-
ous genetic and molecular techniques have been proposed 
to classify the marine mammal Brucella isolates16–19.  
Pacific cetacean Brucella isolates are quite distinct from 
European marine mammal isolates. Therefore it is beli-
eved that Pacific isolates may constitute a separate  
marine mammal species or subspecies19. Marine Brucella 
isolates have distinct genetic and phenotypic characteris-
tics compared to terrestrial mammal isolates20. 
 Brucella infection appears to be widespread among the 
sea mammals. A large number of marine mammals have 
been found to be sero-positive to Brucella antibodies 
around the world13,21–26. The serological evidences of  
marine brucellosis are documented more from the north-
ern hemisphere than the southern hemisphere17,21. Among 
the various species of the sea mammals, Atlantic white-
sided dolphin (Lagenorhynchus acutus) is found to be 
most commonly associated with Brucella infections, 
whereas Stenella coeruleoalba, the striped dolphin is  
reported to be a highly susceptible host and may act as a 
reservoir of Brucella infection13,23,27. Presence of anti-
Brucella antibodies was detected more in Antarctic fur 
seals (Arctocephalus gazella) compared to other species 
of marine mammals tested in Antarctica28. Recently, a 
high (57%) sero-prevalence has been reported among 
Australian fur seals (Arctocephalus pusillus doriferus)26. 
Transmission of marine brucellosis 
The transmission of marine brucellosis is poorly under-
stood. The route of infection and marine mammal reser-
voirs and animal-to-animal transmission remain 
uncertain. Gregarious nature of some of the sea mammals 
is believed to aid in the transmission of brucellosis 
among the sea mammals21,29. Brucella-like organisms 
have also been detected in the lungworms; Pseudalius  
inflexus, lung worm of Pacific harbor seal (P. vitulina 
richardsii) and Halocercus spp., lung worm of bottle 
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nose dolphin30–33. This suggests a potential role of the 
lungworms in transmission of the disease among marine 
mammals30–34. Brucellae have also been isolated from 
longstanding cestodes (Phyllobothrium delphini) from 
bottlenose dolphin33. It may also be possible that species 
down the marine food chain may act as a common source 
of infection to different species of marine mammals35. 
Among terrestrial animals, brucellae are transmitted 
through exposure to infected placenta, birth fluids and 
vaginal secretions, venereal route, milk and through in 
utero transmission3. In marine mammals also, isolations 
of Brucella have been made from milk and mammary 
glands, reproductive organs, placenta, umbilical cord, 
foetal tissues, aborted foetus and secretions of pregnant 
sea mammals. Therefore, marine mammal Brucella iso-
lates also have tropism for placenta and foetal tissues as 
in Brucella-infected terrestrial animals. The vertical 
transmission of the Brucella-infection has been recorded 
and possibility of the horizontal transmission among sea 
mammals cannot be denied. Further, isolation of the or-
ganism from the reproductive organs suggests the possi-
ble sexual transmission of the organism and/or sterility as 
sequelae to infection, similar to those reported in terres-
trial animals7,23,33,34. 
Disease caused by marine mammal Brucella  
isolates 
Disease in marine mammals 
Brucella spp. have been reported from both apparently 
healthy and symptomatic animals36,37. The symptoms or 
clinical syndrome for brucellosis in the sea mammals are 
not clearly documented. Systematic brucellosis appears to 
be common in marine mammals, but it is rarely associ-
ated with pathological changes38. Brucellae have been 
isolated from a wide variety of tissues and from repro-
ductive organs of both the sexes and also from the 
aborted foetuses and placentas13. Brucella spp. in marine 
mammals have been associated with various pathological 
expressions such as subcutaneous lesions, abscesses, hy-
perplastic lymph nodes, congested mammary glands, 
splenic and hepatic necrosis, necrotizing thrombo em-
bolic pneumonia or meningitis/meningoencephalitis and 
abnormal joints and testes, epididymitis and abor-
tions13,21,34. Placentitis and abortions are reported in the 
captive bottlenose dolphins and wild Atlantic white-sided 
dolphin39. Atlantic white-sided dolphins were found to 
have Brucella lesions mainly consisting of hepatic and 
splenic coagulative necrosis, splenomegaly, congested 
lungs, lymphadenitis, mastitis and possible abortions. 
Brucella organisms in marine mammals were also found 
to be associated with oesophageal ulceration and necro-
sis13. Brucella has also been reported as a secondary 
pathogen among stressed porpoises, seals and dolphin13. 
The main pathological findings recorded in porpoise  
(P. phocoena) were blubber abscession, spinal disco-
spondlitis and splenic necrosis13. 
 Brucella can also act as an opportunistic pathogen in 
marine mammals with poor state of nutrition or those suf-
fering from some other disease or parasitism13. Brucella 
as a main etiological agent can cause death due to hepatic 
abscess, peritonitis and epididymitis in marine mam-
mals16,23. Nervous form of the disease resulting in meningo-
encephalitis is seen in striped dolphins only23,38,40. 
Neurobrucellosis is evident by the inability to maintain 
buoyancy, ophisthtonus, tremors and seizures23. Animals 
suffering from nervous form of the disease had hypere-
mic meninges, congested brains and altered cerebrospinal 
fluid23. Brucella organisms were also isolated from adult 
female harbour porpoises with occluded bile duct and 
from the lungs and kidneys of malnourished pups of grey 
seal, Halicherus grypus41. The pregnant animals can  
develop placental abscesses due to Brucella infection23. 
Abnormal testes and caseated and calcified uterus were 
recorded as the main pathological findings among 
Brucella sero-positive common mink whales (Balaenop-
tera acutorostrata) and Bryde’s whales (Balaenoptera 
edeni)42,43. 
Disease in other animals 
The Brucella organisms are known to cross the species 
barrier causing disease in animals other than their pre-
ferred host3,44. Studies indicate that Brucella spp. isolated 
from marine mammals can also cause disease in terres-
trial animals. The disease was induced in cattle, sheep 
and piglets through experimental inoculations with 
Brucella strains isolated from marine mammals. Marine 
Brucella species was re-isolated from the aborted cows 
showing histopathological changes and from various organs 
of unaborted animals with 100% sero-conversion45. 
Sheep inoculated with an isolate of seal origin developed 
a transient low level of anti-Brucella antibodies and the 
microorganism was also isolated from the one of the 
aborted ewes and its foetus46. The organisms were  
re-isolated from lymph nodes of experimentally infected 
pigs. Low and transient antibody titres were detected in 
culture-negative, experimentally infected pigs47. 
 Antibodies against Brucella have also been detected in 
polar bears (Ursus maritimus) from Svalbard and the 
Barents Sea. The ringed seals (Phoca hispida), an impor-
tant prey species for the Svalbard polar bears and harp 
seals (Phoca groenlandica) from the same geographical 
areas were also sero-positive to Brucella antibodies,  
suggesting possible transmission of brucellosis from  
prey to predator48. All these studies suggest that the  
disease occurring in sea mammals can be transmitted to  
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Zoonotic implications of marine brucellosis 
Human brucellosis is essentially an occupational disease. 
Brucella infections in humans occur due to direct or indi-
rect contact with infected animals and/or their discharges, 
and contaminated animal products3. Consumption of con-
taminated animal products such as milk and meat prod-
ucts is major source of infection in man3. Person-to-
person transmission is rare, though it may occur through 
sexual contact49,50, tissue transfer, e.g. bone marrow and 
blood transfusion51,52 and breastfeeding of infants52. In 
addition, laboratory-acquired Brucella infections due to 
accidental ingestion or inhalation, mucosal or skin expo-
sure to infected tissue specimens or cultures of virulent or 
attenuated Brucella strains are major health hazards. The 
aerosols generated during the manipulation of Brucella 
cultures are the commonest source of laboratory infec-
tion53–55. Accidental exposures to animal vaccines can 
cause disease in handlers56. 
 Transmission of brucellosis from marine mammals to 
man is not as extensively reported as Brucella infections 
in marine animals. Interestingly, to date four human cases 
with Brucella infections have been reported presumably 
of marine mammal origin57. Three of these cases were 
acquired through natural infection by marine origin 
Brucella – one case of spinal osteomyelitis from a patient 
in New Zealand58 and two cases of neurobrucellosis from 
Peruvian patients59. Another case of laboratory-acquired 
infection has also been reported55. Cases of zoonotic  
marine brucellosis reported from Peru had serious central 
nervous system disease with intra cerebral granuloma59. 
In both cases there was no direct contact with the marine 
mammals. The patients had history of consumption of 
queso fresco (soft cheese) and raw shell fish ceviche (cit-
rus-marinated seafood) respectively. One had frequently 
swum in the Pacific Ocean, whereas the other seldom vis-
ited the sea coast. However, the mode of transmission in 
these cases remains questionable because of the history of 
regular consumption of unpasteurized cheese59. In New 
Zealand, marine mammal-type Brucella strain was iso-
lated from a patient with no direct exposure to marine 
mammals, but who had a history of regular fishing, con-
tact with uncooked bait and consumption of raw snap-
per58. Isolates from Peruvian patients were similar to  
B. pinnipidae (seal strain), whereas the isolate reported 
from New Zealand was closely related to a Brucella sp. 
originating from a bottlenose dolphin (T. truncatus) in the 
United States and common seals (P. vitulina). All these 
cases can be seen as the early warning signs of an emerg-
ing zoonosis58,59. 
 In general, incubation period of brucellosis in man 
could extend from one week to six months or more. It  
depends upon virulence of the infecting strain, size of the 
inoculum and resistance of the host. Among terrestrial 
strains, B. melitensis is associated with acute infection, 
whereas infections with other species are usually 
subacute and prolonged. Acute form of the disease is 
characterized by intermittent fever (38–41°C), which  
remains normal during the early part of the day and rises 
during the evening. Fever is associated with chills, shiv-
ering, malaise, nausea, extreme fatigue, inappetence and 
loss of body weight. After reaching a peak, the fever sub-
sides rapidly with profuse sweating. Brucellosis also 
causes enlargement of the liver, spleen, superficial lymph 
nodes and abscess formation in the visceral organs. About 
10% of the patients can develop bone and joint complica-
tions such as paravertebral abscess, spondylitis and reac-
tive arthritis3. Nervous form of disease is seen in less than 
5% of patients60. Neurobrucellosis, more commonly asso-
ciated with B. melitensis infection, results in meningitis 
and meningioencephalitis61. Many cases diagnosed as  
tuberculous meningitis are in fact the those of neuro-
brucellosis62. 
 Thrombophlebitis and endocarditis are the most fre-
quent cardiovascular complications of brucellosis. Endo-
carditis is incriminated for a high proportion of mortality 
in brucellosis. Brucellar endocarditis can also be secon-
dary to chronic rheumatic heart disease63,64. Epididymyo-
orchitis is the commonest genitourinary complication in 
males and in pregnant women abortions may occur65. 
Many pregnant women suffering from the acute disease 
have also carried for the full term without any treat-
ment61. In addition, Brucella organisms were also reported 
to cause pneumonia and colitis in human beings65,66. 
 Infection with marine Brucella strains causes a range 
of symptoms, including fever, rigours, headaches, lassi-
tude, sinusitis and lumbar spinal tenderness (spinal  
osteomyelitis). Nervous symptoms include headaches, 
nausea, vomiting, periorbital pain, periodic generalized 
tonic–clonic seizures and progressive deterioration in  
vision. The relative zoonotic potential of marine mam-
malian isolates is yet to be clearly established55,58,59. 
Diagnosis and classification of marine Brucella 
strains 
The symptomatic diagnosis of the brucellosis in marine 
mammals cannot be made as no clinical syndrome has 
been established in the marine mammals. Brucella organ-
isms have been isolated from both normal as well as 
symptomatic/diseased animals. Brucellosis can be diag-
nosed by host preference, serological and molecular tech-
niques, or isolation of the organisms from the affected 
animal. 
Isolation of the organisms from marine mammals 
The majority of isolations of Brucella organism from sea 
mammals were made from dead animals. The organisms 
had been isolated from male and female reproductive  
organs, mammary glands, brain, spinal cord abscesses, 
diseased atlanto-occipital joint, lungs, spleen liver,  
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kidneys, cerebrospinal fluid, joints, foetal tissues, milk,  
secretion of pregnant animals, purulent blubber abscesses 
and a variety of lymph nodes. Isolations had also been 
made from blood cultures collected from heart and lung-
worms of sea mammals. The tissues with or without the 
gross or microscopic changes can provide positive 
Brucella cultures. The oral, nasal, tracheal, vaginal and 
anal swabs and faeces can also be collected for isolation 
of Brucella from live marine mammals13,21–23,27,28,31,41,43. 
Lungs are the primary organs for isolation of Brucella 
from the sea mammals13,21,39. 
 Brucellae are Gram-negative, aerobic and non-motile 
cocco-bacilli. The organism is about 0.5–0.7 μm in dia-
meter and 0.6–1.5 μm in length. It is a fastidious organ-
ism and has specific requirements for the growth21,67,68. 
 Primary isolation of brucellae21,57,68 may take 4–5 days 
and 10% CO2 and a temperature of 37°C. Majority of 
Brucella isolations of organisms from sea mammals are 
done on Farell’s medium, followed by Columbia sheep 
blood agar, Brucella agar with Brucella selective sup-
plement and 1.4% crystal violet and brain heart infusion 
agar with 5 g of yeast extract. Cetacean isolates generally 
become visible within 4 days of inoculation on this  
medium. However, isolates from seals may fail to grow 
or take 7–10 days to grow. The samples should also be 
simultaneously incubated on certain non-selective media 
such as serum dextrose agar or blood agar. Most isolates 
from the pinnipeds are capnophilic, whereas those  
isolated from cetaceans can grow well without CO2. It is 
also recommended that cultures should be discarded as 
negative only after 14 days of incubation13,21,27,29,41,43,67. 
 Marine mammal Brucella isolates have smooth colony 
appearance with entire margins and are raised, convex 
and shiny. These appear as honey coloured and translu-
cent when examined by transmitted light. Brucellae are 
acid-fast in modified Ziehl–Neilson’s staining and show 
agglutination with B. abortus antisera13. Brucella species 
can be differentiated through sero-typing, phage-typing, 
dye sensitivity, CO2 requirement, H2S production and 
other metabolic properties67. Sea mammal Brucella 
strains can be differentiated from the other six Brucella 
species of terrestrial origin through a substrate-specific 
tetrazolium reduction test and phenotypic characters12,69. 
Similar procedures are applied to isolate marine Brucella 
strains from infected human beings55. The importance of 
direct isolation of the organism from the suspected hu-
man cases is stressed since prolonged or chronic illness, 
unknown host factors, symptom-based medication and 
low immunogenicity of the marine Brucella strains may 
result in low or absence of immune responses. 
 Brucella isolates from marine mammals have been 
subdivided into three different biovars on the basis of 
their CO2 requirement, metabolic activity on galactose 
and dominant antigen and animal host12. On the basis of 
differences in host rage, genomic variations and carbohy-
drate metabolism (L-arabinose, D-galactose and D-xylose), 
new names – B. ceti and B. pinnipedialis were proposed 
for isolates from cetaceans and seals respectively16. 
Serological methods 
Serological tests play a crucial role in the brucellosis sur-
veillance programmes. A number of serological tests are 
in use to detect Brucella antibodies or agglutinins in man 
and animals. Each test has its own advantages and limita-
tions in terms of sensitivity and specificity. The smooth 
lipopolysaccharide (S-LPS) is the immunodominant anti-
gen in the Brucella cells. The antibodies against the S-
LPS of Brucella spp. cross-react with S-LPS of other bac-
teria such as Yersinia enterocolitica O9, Escherichia coli 
O157 and Salmonella Urbana resulting in false-positive 
agglutination reactions or misdiagnosis. Moreover,  
absence of agglutinins does not exclude brucellosis, as 
many cases have been recorded in which a positive blood 
culture was obtained despite negative agglutination reac-
tions. It is, therefore, desirable that a battery of sero-
diagnostic tests should be applied to screen a given popu-
lation to detect as many reactors as possible70. 
 The anti-Brucella antibodies have been detected in a 
number of marine mammal species. Serological tests, 
based upon B. abortus antigen, used for marine mammal 
brucellosis diagnosis are similar to those being used to 
diagnose brucellosis in terrestrial animals. These include 
Rose Bengal plate test, serum tube agglutination antigen 
(STAT)/tube agglutination test, ethylenediaminetetraace-
tic acid modified STAT, complement fixation test, card 
agglutination test, buffered acid plate antigens, rivanol 
test, enzyme-linked immunosorbent assays (ELISA), flo-
rescence polarization assays (FPA) and immunoblotting. 
Sero-prevalence of brucellosis varies with the species of 
the animals, number of animals screened, territory or 
area, number and type of tests employed for screen-
ing24,71–79. Threshold values or interpretation of these 
tests are the same as used in the diagnosis of brucellosis 
in terrestrial animals. Validation of these tests in terms of 
the specificity and sensitivity is required for diagnosis of 
brucellosis in various species of sea animals80. A consen-
sus for determining a positive result often requires that a 
marine mammal serum sample tests positive on multiple 
serological tests81. It is likely that the serologic test which 
uses antigen from a marine mammal isolate may be more 
sensitive than those from terrestrial animals. LPS and 
protein antigen determinants may be sufficiently different 
to affect antigen–antibody affinity among different spe-
cies of marine Brucella isolates82. 
 Competitive ELISA (C-ELISA) and FPA were found 
appropriate as diagnostic screening tests for detection of 
Brucella antibodies in marine mammals75. An indirect 
ELISA using terrestrial B. abortus and B. melitensis LPS 
as antigen has been developed for testing odontocete  
serum83. A capture ELISA (cELISA) using whole-cell  
antigen from a harbour seal (P. vitulina) marine Brucella 
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sp. isolate was reported to have high sensitivity but lower 
specificity with cetacean sera. However, specificity and 
sensitivity were both reduced when the same test was ap-
plied on pinniped sera. The marine-origin cELISA was a 
more sensitive assay than the classical B. abortus-based 
tests for detecting anti-Brucella antibodies in both ceta-
cean and pinniped species84. 
Molecular methods 
Molecular or the genomic methods of diagnosis and dif-
ferentiation of Brucella species are more useful than  
serology or culture isolations because of serological 
cross-reactions and fastidious nature of this zoonotic bac-
terium. Molecular analysis has confirmed the genetic dis-
tinctiveness of marine strains from the terrestrial 
strains14,85–88. DNA–DNA hybridization shows that the 
Brucella strains isolated from marine mammals have 
more than 77% DNA relatedness and belong to the mono-
specific genus Brucella. On the basis of ribotyping (Hin-
dIII rDNA restriction patterns), marine isolates were 
classified as a separate subgroup of the genus Brucella86. 
Occurrence of an IS711 element downstream of the bp26 
gene is a feature specific to the marine mammal Brucella 
isolates87. Infrequent restriction site polymerase chain  
reaction (IRS-PCR) targeting IS711 was able to identify 
B. cetaceae and B. pinnipediae separately87. The marine 
mammal isolates were shown to contain a higher number 
of IS711 copies compared to terrestrial mammal isolates 
and at least one specific IS711 copy was detected in all 
the marine isolates89–91. The omp2 locus containing two 
gene copies, omp2a and omp2b, coding for porin proteins 
is useful in molecular typing and identification of Bru-
cella14. Isolates from dolphins and porpoises carry two 
omp2b gene copies instead of one copy each of omp2a 
and one omp2b gene or two similar omp2a gene copies 
reported from earlier recognized Brucella species. omp2b 
gene is a specific marker for grouping the marine mam-
mal Brucella isolates14. The divergence found between 
their omp2b and omp2a nucleotide sequences indicates 
that marine isolates form a more heterogeneous group 
than isolates from terrestrial mammals. Brucellae isolated 
from diverse marine mammal species comprise more than 
one species, and at least two new species, B. pinnipediae 
and B. cetaceae. These two species are compatible with 
the classical classification criteria based on host prefer-
ence and DNA polymorphism at the omp2 locus14. 
 The variable number of tandem repeats (VNTR) typing 
and multilocus sequence analysis differentiated the  
marine mammal brucellae into three major genetic groups. 
One group contains isolates predominantly found in pin-
nipeds (seals) and were previously categorized under spe-
cies B. pinnipediae. B. cetaceae isolates fall into two 
distinct groups that appear to have different preferred  
cetacean hosts (porpoises and dolphins). Interestingly, 
these two groups appear less closely related to each other 
than either group is to B. pinnipediae isolates92. On the 
basis of IRS-PCR, PCR-restriction fragment length 
polymorphism (RFLP) of outer membrane protein (omp) 
genes and IS711 fingerprint profile isolates originating 
from cetaceans and grouped under species B. ceti, fall 
into two clusters. These correspond to isolates with either 
dolphins or porpoises as their preferred host. Isolates 
originating predominantly from seals, and referring to B. 
pinnipedialis, cluster separately and can be further sub-
divided, with isolates from hooded seals comprising a 
distinct group17. Macrorestriction has identified sub-
groups within the pinniped and cetacean isolates and a 
62 kb fragment was found only in pinniped isolates,  
except hooded seal isolates93. Strain typing on the basis 
of multiple locus VNTR analysis comprising 16 loci 
(MLVA-16), B. ceti group was subdivided into a cluster 
each of dolphins, mink whales and porpoises. Isolates 
from dolphins were further sub-divided into two sub-
clusters. Similarly, the B. pinnipedialis group was identi-
fied to have three sub-clusters, one composed exclusively 
of isolates from hooded seals (Cystophora cristata) and 
the two others comprising other seal species isolates20. 
Multilocus sequence typing, classified marine mammal 
isolates into five groups from strain type (ST) 23 to 
ST27. The closely related ST24 and ST25 were composed 
of the pinniped isolates, forming the cluster C. ST26 was 
exclusively composed of dolphin isolates and formed the 
cluster A. The other cetacean isolates fell into cluster B 
(ST23) and consisted of strains isolated from porpoises 
and dolphins. ST27 was represented by only one isolate 
from an aborted bottlenose dolphin foetus originating 
from the Western coast of the United States57,92. 
 A consensus on the nomenclature of Brucella has been 
hard to come by. The International Committee on Sys-
tematic Bacteriology, Subcommittee on the Taxonomy of 
Brucella in 1994, observed the absence of a clear defini-
tion for the concept of species and biovars within the  
genus and agreed on the need to revisit the definition of 
Brucella94. Later, taxonomy of Brucella has been reap-
proved to six Brucella nomenspecies. The previous 
Brucella taxonomy was based on > 90% DNA–DNA  
hybridization identity among brucellae95, and B. meliten-
sis was recommended as a single species with 18 biovars 
and five nomenspecies – B. abortus, B. suis, B. ovis, B. 
neotomae and B. canis. However, this has now been 
changed to the pre-1986 position94. 
Control and prevention of marine brucellosis 
Brucellosis in marine mammals is an emerging zoonotic 
disease. Although marine Brucella strains were recog-
nized recently, the studies conducted till date indicate 
that the disease is probably endemic in marine mammals. 
It has already been indicated that these strains might  
affect the reproductive activities in these animals, which 
is particularly a concern in threatened or naïve species. 
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Brucella organisms have been isolated from a newborn 
Maui dolphin (Cephalorhynchus hectori maui). These are 
considered to be the rarest marine dolphins, with only 
around 100 animals in the world21. The commonest mode 
of infection to human beings seems to be eating of raw or 
undercooked seafood. Marine mammals can shed brucel-
lae actively and isolations have been made from faeces of 
Brucella-positive habour seal96. Direct contaminations of 
these kind pose direct threat to occupationally exposed 
human beings as well as other healthy sea mammals96. In 
view of the vast areas of inhabitation and routes of migra-
tion of the marine mammals, brucellosis can be easily and 
efficiently introduced to new hosts and newer regions and 
such spread of the disease will be difficult to control. 
 Brucella strains are susceptible to a wide range of anti-
biotics in vitro, but fewer antibiotics have proved effec-
tive during the treatment of the disease. WHO recommends 
600–900 mg rifampicin and 200 mg doxycycline as a single 
dose for a minimum of 6 weeks48. Human cases of brucel-
losis with marine brucellosis have been treated success-
fully with combinations of rifampin and tetracycline (8 
weeks)59; rifampin, doxycycline, gentamicin (one week) 
followed by trimethoprim-sulfamethoxazole (one year)59 
and ceftriaxone (6 weeks)58. Laboratory-acquired marine 
Brucella strain infection was successfully treated with a 
combination of rifampin and doxycycline (6 weeks)55. 
Indian perspective 
The presence of brucellosis in India was established in 
the previous century and since then the disease has been 
reported from all over the country97. Brucellosis is con-
sidered to be one of the important but neglected diseases 
in India98. The reported incidence of human brucellosis in 
endemic areas has been reported from < 0.01 to > 200 per 
100,000 population. Data on incidence and economic cost 
of brucellosis in India are not available and it is believed 
that the actual level of disease in the population may be 
much higher, given the level in domestic animal popula-
tions. The Indian Ocean Cetacean Sanctuary was estab-
lished by the International Whaling Commission for 
supporting cetacean research in India. Forty species of 
cetaceans have been recorded from the Indian Ocean re-
gion and 25 species are represented in the Indian waters. 
Of these 25 species, many marine mammalian species are 
either endangered, vulnerable or information on them is 
insufficient. However, marine mammal research is in its 
infancy in India. The lack of research programmes, with 
focused attention on marine mammal biology research in 
India has been responsible for lack of experts on marine 
mammals. As there is poor or no research collaborations 
between veterinary microbiologists and marine mammal 
experts and biologists, any attempt to profile the disease 
status of marine mammals is also lacking. It is important 
that the groups involved in marine mammal conservation 
research in India should forge institutional linkages with 
veterinary research institutions to properly utilize the 
samples collected at the time of strandings or accidental 
entanglements99. 
Recommendations and future strategies 
Marine brucellosis has been considered as an emerging 
hazard for persons occupationally exposed to infected tis-
sues from marine mammals100. Pollution of coastal  
marine waters with human and domesticated animal fae-
cal material has increased due to increase in human popu-
lation, industrialization, urbanization and international 
transportation. This eventually leads scientists to believe 
that marine mammals and avian species may harbour 
these pathogens and become vectors of zoonotic infec-
tions. In order to study and understand such infections, 
future veterinarians must be trained in such fields of 
knowledge like marine mammal veterinary sciences and 
marine farming101. It is important to note that the modes 
transmission of brucellosis from marine mammals to man 
is still questionable. But reports on isolation of marine 
mammal brucellae indicate that people eating raw or un-
cooked food and those involved in recreational activities 
such as swimming are at higher risk of acquiring the  
infection57–59. In spite of marine mammal diversity of  
Indian seas being represented by around 30 recorded spe-
cies, which form one-fourth of the world’s marine mam-
mals and almost 8% of all mammalian fauna recorded in 
India102, studies on marine mammals are limited. However, 
as so far the capacity building for education and research is 
concerned, it is recommended to be based on multi-
disciplinary approaches by cross-linkages among institu-
tions and systems so that it is sustainable and effective103. 
It has been proposed that support for member states for 
strengthening animal disease surveillance systems,  
including those involving aquatic animals, needs to be 
given104. The identification of bacterial diseases afflicting 
our marine mammal biodiversity along our seacoasts is 
important from both sea-mammal and human health per-
spectives. For this, apart from capacity building and 
training for improving the quality of the veterinary ser-
vices and appropriate diagnostic laboratories on the basis 
of adopted standards of the OIE, bringing appropriate 
veterinary legislation and animal health policies, is also 
important105. We also need to understand the epidemiol-
ogy of marine brucellosis, for which a baseline sero-
prevalence epidemiological survey for assessing the real 
situation of marine brucellosis needs to be undertaken. 
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